Evolocumab for the treatment of hypercholesterolemia

Tomlinson, B; Hu, M; Zhang, YZ; Chan, P; Liu, ZM

Chan, P (reprint author), Taipei Med Univ, Wan Fang Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.; Liu, ZM (reprint author), Tongji Univ, Shanghai East Hosp, Dept Cardiac Surg, Shanghai, Peoples R China.

EXPERT OPINION ON BIOLOGICAL THERAPY, 2017; 17 (11): 1447

Abstract

Introduction: Evolocumab is a fully human monoclonal immunoglobulin G2 directed against human proprotein convertase subtilisin/kexin type 9 (PCSK9). I......

Full Text Link